Morgan Stanley’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $499K | Sell |
|
|||||
|
2025
Q1 | $124K | Sell |
|
|||||
|
2024
Q4 | $409K | Sell |
|
|||||
|
2024
Q3 | $831K | Buy |
|
|||||
|
2024
Q2 | $352K | Sell |
|
|||||
|
2024
Q1 | $952K | Sell |
|
|||||
|
2023
Q4 | $984K | Buy |
|
|||||
|
2023
Q3 | $111K | Sell |
|
|||||
|
2023
Q2 | $187K | Buy |
|
|||||
|
2023
Q1 | $111K | Buy |
|
|||||
|
2022
Q4 | $13.8K | Sell |
|
|||||
|
2022
Q3 | $59K | Sell |
|
|||||
|
2022
Q2 | $197K | Buy |
|
|||||
|
2022
Q1 | $64K | Sell |
|
|||||
|
2021
Q4 | $133K | Buy |
|
|||||
|
2021
Q3 | $209K | Sell |
|
|||||
|
2021
Q2 | $728K | Buy |
|
|||||
|
2021
Q1 | $486K | Buy |
|
|||||
|
2020
Q4 | $405K | Buy |
|
|||||
|
2020
Q3 | $33K | Buy |
|